Zymeworks
Patents, Design & Utilities
Last updated:
List of all Zymeworks patents 54 in total
| Status | Patent |
|---|---|
Application | Utility: ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: MODIFIED ANTIGEN BINDING POLYPEPTIDE CONSTRUCTS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ENGINEERED IMMUNOGLOBULIN HEAVY CHAIN-LIGHT CHAIN PAIRS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Bispecific antigen-binding constructs targeting Her2 Filling date: 26 Sep 2025 Issue date: 10 May 2022 |
Application | Utility: METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 FOR THE TREATMENT OF BILIARY TRACT CANCERS Filling date: 26 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Modified antigen binding polypeptide constructs and uses thereof Filling date: 26 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Filling date: 26 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Multivalent heteromultimer scaffold design and constructs Filling date: 26 Sep 2025 Issue date: 15 Feb 2022 |
Application | Utility: BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereof Filling date: 26 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: Antigen-Binding Constructs Targeting HER2 Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES Filling date: 26 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: Antigen-Binding Polypeptide Constructs Comprising Kappa and Lambda Light Chains and Uses Thereof Filling date: 26 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof Filling date: 26 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics Filling date: 26 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Drug-conjugated bi-specific antigen-binding constructs Filling date: 26 Sep 2025 Issue date: 19 Oct 2021 |
Application | Utility: Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: Engineered Immunoglobulin Heavy Chain-Light Chain Pairs and Uses Thereof Filling date: 26 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: METHODS USING MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 26 Aug 2021 |
Grant | Utility: Heteromultimers with reduced or silenced effector function Filling date: 26 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Filling date: 26 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Anti-PD-1/LAG3 bispecific antibodies Filling date: 26 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 IN COMBINATION WITH CDK4/6 INHIBITORS FOR THE TREATMENT OF BREAST CANCER Filling date: 26 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Antigen-binding constructs targeting HER2 Filling date: 26 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Systems and methods for identifying thermodynamically relevant polymer conformations Filling date: 26 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Anti-HER2 biparatopic antibody-drug conjugates and methods of use Filling date: 26 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Bispecific antigen-binding constructs targeting HER2 Filling date: 26 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS Filling date: 26 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Stable heterodimeric antibody design with mutations in the Fc domain Filling date: 26 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: STABILIZED CHIMERIC FABS Filling date: 26 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Filling date: 26 Sep 2025 Issue date: 24 Sep 2020 |
Grant | Utility: Multivalent heteromultimer scaffold design and constructs Filling date: 26 Sep 2025 Issue date: 14 Jul 2020 |
Application | Utility: CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME Filling date: 26 Sep 2025 Issue date: 2 Jul 2020 |
Grant | Utility: VAR2CSA-drug conjugates Filling date: 26 Sep 2025 Issue date: 9 Jun 2020 |
Application | Utility: ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN Filling date: 26 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: TUMOR ANTIGEN PRESENTATION INDUCER CONSTRUCTS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Compositions and methods for the treatment of platinum-drug resistant cancer Filling date: 26 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells Filling date: 26 Sep 2025 Issue date: 17 Dec 2019 |
Application | Utility: MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS Filling date: 26 Sep 2025 Issue date: 12 Dec 2019 |
Grant | Utility: Systems and methods for sampling and analysis of polymer conformational dynamics Filling date: 26 Sep 2025 Issue date: 19 Nov 2019 |
Application | Utility: CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME Filling date: 26 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Antigen-Binding Polypeptide Constructs Comprising Kappa and Lambda Light Chains and Uses Thereof Filling date: 26 Sep 2025 Issue date: 7 Nov 2019 |
Grant | Utility: Stable heterodimeric antibody design with mutations in the Fc domain Filling date: 26 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Cytotoxic and anti-mitotic compounds, and methods of using the same Filling date: 26 Sep 2025 Issue date: 22 Oct 2019 |
Showing 1 to 50 of 54 patents.